Pure Bio Labs PT-141 is research-grade bremelanotide sold for lab use only. Compare formats, timelines, storage, and safety basics before you buy.
Pure Bio Labs PT-141 is a research-grade form of bremelanotide, a synthetic melanocortin receptor agonist peptide sold as a lyophilized powder or a premixed liquid and labeled strictly for laboratory use. It is not an FDA-approved drug, and no vendor version of it has been reviewed for human safety or dosing. This guide explains what these listings typically contain, how the formats compare, and what US buyers should verify before ordering.
What Is PT-141 (Bremelanotide)?
PT-141 is the original research code for bremelanotide, a cyclic heptapeptide modeled on alpha-melanocyte-stimulating hormone. It acts on melanocortin receptors, particularly MC4R, the pathway researchers link to central effects on sexual desire.
The FDA approved bremelanotide as Vyleesi in 2019 for hypoactive sexual desire disorder in premenopausal women. It is dispensed as a 1.75 mg subcutaneous auto-injector and is not approved for men or for any other use.
Bremelanotide is FDA-approved only as Vyleesi; the PT-141 sold under research labels is not approved for human use in the United States.
What Pure Bio Labs PT-141 Typically Contains
Vendors in this category, including Pure Bio Labs, generally follow the same catalog format for peptide products.
- Vial size: 10 mg of lyophilized powder is the most common listing, though nasal spray formats are also advertised.
- Documentation: a certificate of analysis (COA) showing HPLC purity and mass spectrometry confirmation.
- Separate supplies: bacteriostatic water and sterile vials are usually sold as add-ons.
- Labeling: "for research use only — not for human or veterinary use."
Batch quality varies even within a single brand, so the lot number and its matching lab report matter more than the product page copy. A certificate of analysis without a traceable lot number is close to meaningless.
Formats Compared: Powder, Nasal Spray, and Prescription Injection
| Format | Typical size | What to know |
|---|---|---|
| Lyophilized powder vial | 10 mg | Requires reconstitution, cold storage, and sterile technique |
| Pre-mixed nasal spray | Varies by vendor | Sterility and actual concentration are rarely independently verified |
| Prescription auto-injector (Vyleesi) | 1.75 mg per dose | FDA-approved, pharmacy-dispensed, single-use |
Much of the online discussion frames the choice as pt-141 nasal spray vs injection, because the routes differ in absorption, peak concentration, and dose consistency. Published pharmacokinetic data exist mainly for subcutaneous delivery, and controlled intranasal data remain thin.
A pt-141 bremelanotide injection 20mg vial from a research supplier holds far more material than any single clinical dose, which is one reason the "not for human use" label exists: the packaging is not designed for people.
Reported Onset and Duration in the Research Literature
In clinical studies of subcutaneous bremelanotide, plasma concentrations rose within roughly 30 to 60 minutes, and reported effects were tracked over the hours that followed. People asking how long does pt-141 last are usually asking about that window, and the honest answer depends on dose, route, and the individual.
Queries about pt-141 how long does it take to work trace back to the same trial data. Nothing in the peer-reviewed record supports the multi-day durations sometimes claimed for nasal or oral versions on vendor pages.
Published data for subcutaneous bremelanotide describe onset within about 30 to 60 minutes, with effects typically reported over the following hours.
Storage, Handling, and Purity Verification
Peptide integrity depends heavily on how the material is stored and handled.
- Keep lyophilized powder at -20 °C, away from light and moisture.
- Reconstitute with sterile or bacteriostatic water and swirl gently rather than shaking.
- Refrigerate the reconstituted solution and avoid repeated freeze-thaw cycles.
- Match the vial's lot number to an independent HPLC purity report before use in any assay.
Nasal formats add a sterility requirement that most research vendors do not document, which limits how useful they are in a controlled setting. Home-made nasal formulations are riskier still, since sterilization and accurate concentration are difficult to achieve outside a proper facility.
Safety, Legal Status, and Vendor Vetting
Research-grade PT-141 carries a research-use-only label because it has not been reviewed by the FDA for human safety, dosing, or efficacy. That label is a legal statement, not a marketing preference.
Side effects reported in bremelanotide trials included nausea, flushing, headache, and injection-site reactions. Trials also noted transient blood pressure increases, and the approved product warns against use in people with uncontrolled hypertension or cardiovascular disease.
Anyone considering bremelanotide for a medical purpose should speak with a licensed healthcare professional instead of self-dosing with a research chemical.
Vetting a Vendor Before You Order
People who search for where to buy pt-141 land on a mix of research suppliers, overseas pharmacies, and forums, and those categories are not equivalent.
- Independent testing: prefer a third-party lab report over an in-house COA.
- Batch traceability: the lot number on the vial should match the document.
- Cold-chain shipping: temperature control in transit affects peptide stability.
- Honest labeling: a legitimate research vendor states "not for human use" on the product itself.
Importing a prescription drug such as bremelanotide without a prescription is not legal in the United States, and a research label does not change that. Buyers should also treat any vendor promising guaranteed results or clinical dosing guidance as a red flag.
Frequently Asked Questions
Is Pure Bio Labs PT-141 FDA-approved?
No. Research-grade PT-141 is labeled for laboratory use only and has not been reviewed by the FDA for human safety or effectiveness. Bremelanotide is FDA-approved only as Vyleesi, a 1.75 mg prescription auto-injector for hypoactive sexual desire disorder in premenopausal women.
How long does PT-141 take to work?
In clinical trials of the subcutaneous injectable, plasma levels rose within roughly 30 to 60 minutes, with reported effects tracked over the hours that followed. Research-grade powder and nasal products sold online have not been studied that way, so no reliable timeline can be quoted for them.
Is it legal to buy PT-141 online in the US?
Research chemicals labeled "not for human use" sit in an uncertain regulatory space, and importing prescription bremelanotide without a prescription is not legal. Purity, sterility, and actual peptide content are also unverified on most listings, which makes personal use risky.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.